Hunterian Medicine
Cambridge
About Hunterian Medicine
Hunterian Medicine is a biotech company that develops cures for a vast number of genetic diseases where no FDA approved therapies exist. It is poised to unleash the full potential of CRISPR. Its patented platform technology solves the CRISPR delivery problem by enabling efficient, on-target delivery through a single adeno-associated virus (AAV). The Company was founded in 2016 and is headquartered in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.8M
- Last round: Grant (May 2021)
- Website: hunterian.com
- Phone: 888-486-8633
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/hunterian-medicine-139492 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.